Abstract
To ensure that vulnerable groups face minimum challenges and benefit from improved health financing, we urge national and international institutions worldwide to use and adopt AI tools and applications.
Introduction: Beyond Clinical Diagnostics
While much of the public discourse surrounding Artificial Intelligence (AI) in healthcare focuses on clinical diagnostics and personalized medicine, a critical transformation is occurring in the "engine room" of healthcare systems: health financing. As nations strive toward Universal Health Coverage (UHC), the complexity of managing revenue collection, fund pooling, and strategic purchasing has outpaced traditional actuarial models.
Healthcare systems are currently grappling with "high data dimensionality"—a vast array of variables including demographics, complex comorbidities, and social determinants of health. Traditional linear models often fail to capture the non-linear, time-variant nature of real-world financial systems. This paper addresses the urgent need for "intelligent" systems capable of predicting financial risks, detecting fraud, and ensuring resource allocation reaches the most vulnerable populations without causing "financial toxicity."
Methods: Mapping the AI Landscape
The researchers conducted a comprehensive scoping review following the Arksey and O’Malley framework. Unlike a systematic review designed to answer a narrow clinical question, this scoping review aimed to map the breadth of AI applications within the health financing domain.
The methodology involved a six-step process:
- Formulating research questions regarding current and future AI applications.
- Literature search across major databases including PubMed, Scopus, and Web of Science for the period 2000–2023.
- Screening of initial records to identify relevant studies.
- Data charting to categorize findings.
- Summarizing results into a new conceptual framework.
- Expert consultation to validate the findings.
From an initial pool of 1,179 records, the team identified 118 studies that met the inclusion criteria, forming the basis for the synthesis of AI's impact on health financing.
Data Sources and Synthesis
The review synthesized findings from a diverse range of data sources, reflecting the multi-faceted nature of health finance:
- National Health Insurance Databases: Utilizing large-scale claims data from countries such as South Korea, Taiwan, and Poland.
- Macroeconomic Data: Incorporating GDP, inflation rates, and government expenditure metrics.
- Clinical and Socioeconomic Data: Leveraging Electronic Health Records (EHRs), patient demographics, and lifestyle factors like BMI and smoking status.
- Geospatial Data: Employing "GeoDetectors" to analyze the impact of environmental factors, such as air pollution, on health spending.
Key Results: A New Framework for Health Financing
The study organizes AI applications into four primary functional domains: Governance, Revenue Raising, Pooling, and Strategic Purchasing. This categorization allows for a structured understanding of how AI capabilities translate into specific financial goals and plans.
1. Governance
AI facilitates the automation of health project classification and tracks fund flows for "global common goods." It enhances efficiency in simulating emergency material preparation, ensuring systems are resilient to shocks.
2. Revenue Raising
Machine Learning (ML) models, such as K-Nearest Neighbor, are increasingly used to forecast GDP growth and tax revenue with higher accuracy than traditional time-series analysis. This precision helps governments plan sustainable long-term health budgets and even calculate "optimal" taxes on negative externalities (e.g., meat consumption or pollution) to generate revenue while improving public health.
3. Pooling
AI identifies "high-utilizers" and predicts insurance premiums based on real-world risk factors rather than broad averages. Recommender systems, such as OptiHealth, empower consumers to select the most cost-effective insurance plans tailored to their specific needs.
4. Strategic Purchasing
AI optimizes "Diagnosis-Related Group" (DRG) systems, which are essential for determining hospital payouts. Furthermore, it improves the integrity of performance-based financing (PBF) by verifying service delivery and detecting "abusive utilization patterns" or fraudulent billing more effectively than manual audits.
Discussion: Moving from Average to Individual
A core insight of this review is the shift from population-level averages to individual-level precision. AI allows policymakers to move from asking "Is this policy effective on average?" to "Who is this policy effective for?" This granularity is vital for preventing "financial toxicity"—the economic ruin of patients due to medical bills—by predicting a patient's risk before treatment begins and allowing for early intervention through social support or adjusted payment plans.
Limitations and Future Directions
Despite the promising findings, the authors highlight several critical gaps that must be addressed:
- Ethics and Privacy: There is a notable lack of deep discussion regarding the ethical implications and privacy risks associated with using sensitive health and financial data in AI models.
- Real-World Validation: Many current studies rely on simulated data or small-scale pilot programs. Future research must utilize "actual" health finance data at scale to prove real-world efficacy.
- Interdisciplinary Silos: Research remains largely siloed within the finance sector. The authors urge for cross-disciplinary studies that link health financing AI with other health system building blocks, such as workforce management and service delivery.
- Negative Impacts: The current literature lacks a critical examination of potential failures or negative unintended consequences of AI implementations in this space.
Summary updated